BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32135041)

  • 21. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
    Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
    Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence.
    Zheng B; Ohuchida K; Yan Z; Okumura T; Ohtsuka T; Nakamura M
    World J Surg; 2017 Nov; 41(11):2858-2866. PubMed ID: 28634843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive venous invasion in the area of carcinoma correlates with liver metastasis as an index of metastasis for invasive ductal carcinoma of the pancreas.
    Hamada Y; Nakayama Y
    Pancreatology; 2017; 17(6):951-955. PubMed ID: 28844697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
    Zhao KL; Liu J; Jiang WN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
    Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
    Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin.
    Italiano A; Toulmonde M; Stoeckle E; Kind M; Kantor G; Coindre JM; Bui B
    Ann Oncol; 2010 Sep; 21(9):1915-1921. PubMed ID: 20167595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study.
    Beger HG; Link KH; Gansauge F
    Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
    Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
    World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
    Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
    Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.
    Owusu-Ansah KG; Song G; Chen R; Edoo MIA; Li J; Chen B; Wu J; Zhou L; Xie H; Jiang D; Zheng S
    Int J Oncol; 2019 Aug; 55(2):391-404. PubMed ID: 31268154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.
    Seo Y; Baba H; Fukuda T; Takashima M; Sugimachi K
    Cancer; 2000 May; 88(10):2239-45. PubMed ID: 10820344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy].
    Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1].
    Fujito T; Goda F; Matsuyama J; Hojo S; Yano Y; Endo W; Yamazaki K; Maeura Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):293-6. PubMed ID: 12610882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
    Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
    Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.
    Cloyd JM; Omichi K; Mizuno T; Kawaguchi Y; Tzeng CD; Conrad C; Chun YS; Aloia TA; Katz MHG; Lee JE; Halperin D; Yao J; Vauthey JN; Dasari A
    Ann Surg Oncol; 2018 Jun; 25(6):1709-1715. PubMed ID: 29626307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.